摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[(2-methoxycarbonylphenylamino)methylene]malonic acid diethyl ester | 42063-41-2

中文名称
——
中文别名
——
英文名称
2-[(2-methoxycarbonylphenylamino)methylene]malonic acid diethyl ester
英文别名
diethyl 2-(((2-(methoxycarbonyl)phenyl)amino)methylene)malonate;<(2-Methoxycarbonyl-anilino)-methylen>-malonsaeure-diaethylester;2-<2'.2'-Bis(carbethoxy)vinylamino>-benzoesaeuremethylester;N-<2,2-Diethoxy-carbonyl-vinyl>-enthranilsaeuremethylester;N-(2,2-Diethoxy-carbonyl-vinyl)-enthranilsaeuremethylester;Diethyl 2-[(2-methoxycarbonylanilino)methylidene]propanedioate
2-[(2-methoxycarbonylphenylamino)methylene]malonic acid diethyl ester化学式
CAS
42063-41-2
化学式
C16H19NO6
mdl
——
分子量
321.33
InChiKey
GAABFJPVSRYSEQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    40 °C
  • 沸点:
    401.8±45.0 °C(Predicted)
  • 密度:
    1.223±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    23
  • 可旋转键数:
    10
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    90.9
  • 氢给体数:
    1
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-[(2-methoxycarbonylphenylamino)methylene]malonic acid diethyl ester乙二胺 作用下, 以 乙醇 为溶剂, 反应 2.3h, 以96%的产率得到邻氨基苯甲酸甲酯
    参考文献:
    名称:
    2,2-双(乙氧羰基)乙烯基(BECV)作为多功能胺的保护基团,用于选择性官能团转化
    摘要:
    在室温下,存在潜在干扰官能团(例如OH,SH,COOH以及其他NH 2基团)的情况下,将2,2-双(乙氧羰基)乙烯基(BECV)基团用于胺的选择性保护。在BECV基团存在的情况下,可以选择性地进行一些官能团转化,例如酯化,O-烷基化,O-酰化,N-烷基化,N-酰化,S-烷基化。在室温下,使用乙二胺可在短时间内实现BECV基团的选择性脱保护,而其他一些官能团(如苯甲酸酯,脂族酯,酰胺和醚)则保持完整。BECV基团显示出对常见保护基(如Fmoc,Cbz和Boc)的正交稳定性。
    DOI:
    10.1002/chem.200902054
  • 作为产物:
    描述:
    邻氨基苯甲酸甲酯乙氧基甲叉丙二酸二乙酯 以 neat (no solvent) 为溶剂, 以90%的产率得到2-[(2-methoxycarbonylphenylamino)methylene]malonic acid diethyl ester
    参考文献:
    名称:
    铑螯合辅助的C-O键活化催化未活化酯形成酮
    摘要:
    开发了一种新的方法,该方法通过铑配合物催化的螯合辅助C–O键活化来构建含杂环的芳基芳基酮。在该反应中,在铑(I)络合物的存在下,使喹啉8-羧酸甲酯,喹喔啉-5-羧酸甲酯及其衍生物与过量的取代的苯基硼酸反应,得到取代的苯基(喹啉-中高收率的8-基)甲酮,苯基喹喔啉-5-基甲酮及其衍生物。当前的方法提供了非常有利的合成途径,以有效地构建具有8-苯甲酰基喹啉核心结构的相关药物。这种方法对于药物化学家来说可能是特别有价值的,因为它可以将多功能酮部分后期引入复杂的支架中,从而实现面向多样性的合成策略。
    DOI:
    10.1021/jo400949p
点击查看最新优质反应信息

文献信息

  • Diethyl malonate as leaving group: Facile synthesis of some 1,3,4-benzotriazepines and benzotriazepinones
    作者:C. Podesva、G. Kohan、K. Vagi
    DOI:10.1139/v69-071
    日期:1969.2.1

    Reaction between 2-(2′,2′-bis-carboethoxyvinylamino)-benzophenones, resulting from the condensation of 2-aminobenzophenones with diethyl ethoxymethylenemalonate, and hydrazine hydrate yields 5-hydroxy-5-phenyl-1,3,4-3H-4,5-dihydrobenzotriazepines or their double bond isomers. These products on acetylation afford O,N,N-triacetates, which on treatment with ammonia are transformed into 4-phenylquinazolines. Structure proof of these substances is reported.

    2-(2′,2′-双羧乙氧基乙烯基氨基)-苯并酮与双乙酸乙氧甲基亚甲基丙二酸二乙酯缩合生成的产物与水合肼反应,得到5-羟基-5-苯基-1,3,4-3H-4,5-二氢苯并三氮杂环庚烯或其双键异构体。这些产物在乙酰化后形成O,N,N-三乙酸酯,经氨处理后转化为4-苯基喹唑啉。报道了这些物质的结构证明。
  • Ethene derivatives
    申请人:MAY & BAKER LIMITED
    公开号:EP0174832A2
    公开(公告)日:1986-03-19
    Ethene derivatives of the general formula: wherein R5 represents a heterocyclyl group, containing 1, 2 or 3 rings and one or more heteroatoms selected from nitrogen, oxygen, sulphur and selenium atoms, which is unsubstituted or substituted by one or more substituents R8 [which may be the same or different and each represents a halogen atom or an amino, carboxy, cyano, nitro, hydroxy, oxo, formyl, trifluoromethyl, aryl, aryloxy, arylthio, benzyloxycarbonylamino, sulphamoyl, tetrazol-5-yl, carbamoyl, thiocarbamoyl, arylcarbamoyl or aroyl group, or a straight-or branched-chain alkyl group containing from 1 to 10 carbon atoms, or a straight- or branched-chain alkoxy, alkylthio, alkylsulphinyl, alkylsulphonyl, alkylamino, alkylsulphamoyl, arylalkyl or arylalkoxy group containing from 1 to 10 carbon atoms in the alkyl moiety, a straight- or branched-chain alkanoyl, alkoxycarbonyl, alkoxycarbonylamino, alkylcarbamoyl or alkanoylamino group containing from 2 to 6 carbon atoms, an N-benzyloxycarbonyl-N-alkylamino group wherein the alkylamino moiety is straight- or branched-chain and contains from 1 to 6 carbon atoms, or a dialkylsulphamoyl, dialkylamino or dialkylcarbamoyl group wherein the alkyl moieties may be straight or branched and may each contain from 1 to 6 carbon atoms and may be linked together to form a ring, or a group of the formula -CR4=CR2R3, or an aryl group which is unsubstituted or substituted by one or more substituents RS (as hereinbefore defined), or a heterocyclylalkyl or arylalkyl group wherein the heterocyclyl or aryl moiety is as hereinbefore defined and the alkyl moiety is straight- or branched-chain and contains 1 or 2 carbons atoms, and R1 represents a group of the general formula: wherein R6 represents a hydrogen atom or a straight- or branched-chain alkyl group containing from 1 to 6 carbon atoms which may be substituted by one or more substituents RS (as hereinbefore defined) or an aryl group which may be substituted by one or more substituents R8 (as hereinbefore defined), or R5 represents a quinonoidal group R7 derived from a nitrogen-containing heterocyclyl group within the definition of R5 as hereinbefore defined, bearing on said ring-nitrogen atom a substituent selected from straight- and branched-chain alkyl groups containing from 1 to 6 carbon atoms which may be substituted by one or more substituents RS (as hereinbefore defined), and aryl groups which may be substituted by one or more substituents RS (as hereinbefore defined), and R1 represents an atom =N-, R4 represents a hydrogen atom or a straight- or branched-chain alkoxy or alkylthio group containing from 1 to 6 carbon atoms, a trifluoromethyl group or a straight- or branched-chain alkyl group containing from 1 to 6 carbon atoms which may be substituted by one or more substituents R8 (as hereinbefore defined), or an aryl group which may be substituted by one or more substituents R8 (as hereinbefore defined), R2 represents a cyano or formyl group, a straight- or branched-chain alkoxycarbonyl or alkylsulphonyl group containing up to 6 carbons, or a dialkylcarbamoyl or dialkylthiocarbamoyl group wherein the alkyl groups may be the same or different and each may be straight or branched and each contains from 1 to 6 carbon atoms, or an aryloxycarbonyl, arylsulphinyl or arylsulphonyl group wherein the aryl moiety may be substituted by one or more substituents R8 (as hereinbefore defined), R3 represents a group within the definition of R2 or a hydrogen atom or a nitro group or an aryl or aroyl group which may be substituted by one or more substituents R8 (as hereinbefore defined) or a straight- or branched-chain alkanoyl group containing up to 6 carbon atoms, and m and n each represents 1 or 2, and pharmaceutically acceptable salts thereof, with the provisos that the following classes of compounds are excluded:- (i) compounds of formula I wherein R5 represents a pyridyl group which is unsubstituted or substituted by one or more substituents R9 which may be the same or different and each represents a group within the definition of Re other than oxo, straight- or branched-chain alkyl containing from 7 to 10 carbon atoms, straight- or branched-chain alkoxy, alkylthio, alkylsulphonyl, alkylamino, alkylsulphamoyl or arylalkyl containing from 7 to 10 carbon atoms in the alkyl moiety, straight- or branched-chain alkylsulphinyl or arylalkoxy containing from 1 to 10 carbon atoms in the alkyl moiety, or a group -CR4=CR2R3 as hereinbefore defined, R2 and R3 may be the same or different and each represents a phenylsulphonyl group which may be unsubstituted or substituted by one or more substituents R9 (as hereinbefore defined), R' represents a group of formula II, R4 and R6 represent hydrogen atoms and m and n both represent 1; (ii) compounds of formula I wherein R5 represents a 5-halogenopyrid-2-yl group, R2 and R3 both represent cyano groups, R1 represents a group of formula II, R4 and R° represent hydrogen atoms and m and n both represent 1; and (iii) compounds of formula I wherein R5 represents a 1,2,4-triazolo[4,8-a]-quinoline group which is unsubstituted or substituted by one or more substituents R10 which may be the same or different and each represents a group within the definition of R9 or a straight- or branched-chain alkylsulphinyl group containing from 1 to 6 carbon atoms, R2 and R3 may be the same or different and each represents a cyano group, a straight- or branched-chain alkoxycarbonyl group containing from 2 to 6 carbon atoms, or a phenylsulphonyl group which may be unsubstituted or substituted by one or more substituents R10 (as hereinbefore defined), R' represents a group of formula II, R4 and R6 represent hydrogen atoms and m and n both represent 1, possess useful pharmacological properties.
    以下是对文本的中文翻译: **丙烯衍生物的通式**: 其中,R5代表一个杂环基,包含1、2或3个环,并且含有1个或多个选自氮、氧、硫和硒原子的杂原子,该杂环基可以是未取代的,或被一个或多个R8取代基取代(R8可以相同或不同,每个R8代表一个卤素原子;或者一个氨基、羧基、氰基、硝基、羟基、羰基、甲酰基、三氟甲基、芳基、芳氧基、芳硫基、苄氧羰基氨基、硫脲基、5-四唑基、羰基氨基、硫代羰基氨基、芳基羰基氨基或芳酰基;或者一个直链或支链烷基,含有1至10个碳原子;或者一个直链或支链烷氧基、烷硫基、烷亚砜基、烷砜基、烷氨基、烷硫脲基、芳基烷基或芳基烷氧基,其中烷基部分含有1至10个碳原子;或者一个直链或支链烷酰基、烷氧基羰基、烷氧基羰基氨基、烷基羰基氨基或烷酰基氨基,含有2至6个碳原子;或者一个N-苄氧羰基-N-烷基氨基,其中烷基氨基部分为直链或支链,含有1至6个碳原子;或者一个二烷基硫脲基、二烷基氨基或二烷基羰基氨基,其中烷基部分可以为直链或支链,每个烷基部分含有1至6个碳原子,且烷基部分可以彼此连接形成一个环;或者一个通式为-CR4=CR2R3的基团;或者一个未取代的芳基,或被一个或多个R8取代基取代的芳基;或者一个杂环基烷基或芳基烷基,其中杂环基或芳基部分如前所定义,烷基部分为直链或支链,含有1或2个碳原子)。 R1代表一个通式为的基团: 其中,R6代表一个氢原子;或一个直链或支链烷基,含有1至6个碳原子,该烷基可以被一个或多个R8取代基取代(如前所定义);或一个芳基,可以被一个或多个R8取代基取代(如前所定义)。 此外,R5还可以代表一个由含氮杂环基衍生而来的醌状基团R7,该杂环基如前所定义的R5,其中环氮原子上取代有一个选自以下的基团:直链或支链烷基,含有1至6个碳原子,该烷基可以被一个或多个R8取代基取代(如前所定义);或一个芳基,可以被一个或多个R8取代基取代(如前所定义)。 R1代表一个=NH原子;R4代表一个氢原子,或一个直链或支链烷氧基、烷硫基,含有1至6个碳原子;或一个三氟甲基基团;或一个直链或支链烷基,含有1至6个碳原子,该烷基可以被一个或多个R8取代基取代(如前所定义);或一个芳基,可以被一个或多个R8取代基取代(如前所定义)。 R2代表一个氰基或甲酰基;或一个直链或支链烷氧基羰基或烷硫基,含有不超过6个碳原子;或一个二烷基羰基氨基或二烷基硫代羰基氨基,其中两个烷基可以相同或不同,每个烷基为直链或支链,含有1至6个碳原子;或一个芳氧基羰基、芳硫基或芳硫基羰基,其中芳基部分可以被一个或多个R8取代基取代(如前所定义)。 R3代表一个与R2定义范围内的基团,或一个氢原子;或一个硝基;或一个芳基;或一个芳酰基,可以被一个或多个R8取代基取代(如前所定义);或一个直链或支链烷酰基,含有不超过6个碳原子。 m和n各自代表1或2。 除以下化合物类别外,上述结构及其药学上可接受的盐类具有有用的药理学性质: (i) 通式为I的化合物,其中R5代表一个吡啶基,该吡啶基可以是未取代的,或被一个或多个R9取代基取代,R9可以相同或不同,每个R9代表一个基团,其定义范围包括:R8(但不包括氧代基、直链或支链烷基,含有7至10个碳原子;直链或支链烷氧基、烷硫基、烷硫基、烷氨基、烷硫脲基、或芳基烷基,其中烷基部分含有7至10个碳原子;直链或支链烷亚砜基,或芳基烷氧基,其中烷基部分含有1至10个碳原子);或一个如前所定义的-CR4=CR2R3基团。其中,R2和R3可以相同或不同,各自代表一个苯硫基,可以是未取代的,或被一个或多个R9取代基取代(如前所定义)。R’代表一个通式II的基团。R4和R6代表氢原子,m和n均为1。 (ii) 通式为I的化合物,其中R5代表一个5-卤素取代吡啶-2-基,R2和R3均为氰基,R1代表一个通式II的基团,R4和R°代表氢原子,m和n均为1。 (iii) 通式为I的化合物,其中R5代表一个1,2,4-三唑[4,8-a]-喹啉基,该基团可以是未取代的,或被一个或多个R10取代基取代,R10可以相同或不同,每个R10代表一个基团,其定义范围包括:R9(如前所定义),或一个直链或支链烷亚砜基,含有1至6个碳原子。R2和R3可以相同或不同,各自代表一个氰基、一个直链或支链烷氧基羰基(含有2至6个碳原子),或一个苯硫基,可以是未取代的,或被一个或多个R10取代基取代(如前所定义)。R’代表一个通式II的基团。R4和R6代表氢原子,m和n均为1。 上述化合物在排除了特定结构后,具有有用的药理学性质。
  • Enamine Derivatives of Malonic Acid with Pharmacologic Activities
    作者:Arthur A. Santilli、William F. Bruce、T. S. Osdene
    DOI:10.1021/jm00331a015
    日期:1964.1
  • Catalytic Formation of Ketones from Unactivated Esters through Rhodium Chelation-Assisted C–O Bond Activation
    作者:Jingjing Wang、Sujing Zuo、Weiqiang Chen、Xinrui Zhang、Kaixin Tan、Yun Tian、Jianhui Wang
    DOI:10.1021/jo400949p
    日期:2013.9.6
    A new method for building aryl aryl ketones containing heterocyclic rings through chelation-assisted C–O bond activation catalyzed by a rhodium complex has been developed. In this reaction, methyl quinoline-8-carboxylate, methyl quinoxaline-5-carboxylate, and their derivatives were reacted with an excess amount of a substituted phenyl boronic acid in the presence of a rhodium(I) complex to give substituted
    开发了一种新的方法,该方法通过铑配合物催化的螯合辅助C–O键活化来构建含杂环的芳基芳基酮。在该反应中,在铑(I)络合物的存在下,使喹啉8-羧酸甲酯,喹喔啉-5-羧酸甲酯及其衍生物与过量的取代的苯基硼酸反应,得到取代的苯基(喹啉-中高收率的8-基)甲酮,苯基喹喔啉-5-基甲酮及其衍生物。当前的方法提供了非常有利的合成途径,以有效地构建具有8-苯甲酰基喹啉核心结构的相关药物。这种方法对于药物化学家来说可能是特别有价值的,因为它可以将多功能酮部分后期引入复杂的支架中,从而实现面向多样性的合成策略。
  • 2,2-Bis(ethoxycarbonyl)vinyl (BECV) as a Versatile Amine Protecting Group for Selective Functional-Group Transformations
    作者:Andivelu Ilangovan、Rajendran Ganesh Kumar
    DOI:10.1002/chem.200902054
    日期:——
    used for the selective protection of amines at room temperature in the presence of potentially interfering functional groups such as OH, SH, COOH as well as other NH2 groups. Several functional group transformations such as esterification, O‐alkylation, O‐acylation, N‐alkylation, N‐acylation, S‐alkylation can selectively be carried out in the presence of the BECV group. The selective deprotection of
    在室温下,存在潜在干扰官能团(例如OH,SH,COOH以及其他NH 2基团)的情况下,将2,2-双(乙氧羰基)乙烯基(BECV)基团用于胺的选择性保护。在BECV基团存在的情况下,可以选择性地进行一些官能团转化,例如酯化,O-烷基化,O-酰化,N-烷基化,N-酰化,S-烷基化。在室温下,使用乙二胺可在短时间内实现BECV基团的选择性脱保护,而其他一些官能团(如苯甲酸酯,脂族酯,酰胺和醚)则保持完整。BECV基团显示出对常见保护基(如Fmoc,Cbz和Boc)的正交稳定性。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐